GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0001 $0.0001 Wednesday, 19th Apr 2023 GNCA stock ended at $0.0001. During the day the stock fluctuated 0% from a day low at $0.0001 to a day high of $0.0001.
90 days $0.0001 $0.0001
52 weeks $0.0001 $0.469

Historical Genocea Biosciences prices

Date Open High Low Close Volume
2022-09-13 $0.0092 $0.0122 $0.0092 $0.0099 84 660
2022-09-12 $0.0100 $0.0112 $0.0091 $0.0095 587 876
2022-09-09 $0.0103 $0.0112 $0.0091 $0.0112 85 689
2022-09-08 $0.0120 $0.0120 $0.0092 $0.0095 72 898
2022-09-07 $0.0091 $0.0099 $0.0091 $0.0095 118 099
2022-09-06 $0.0110 $0.0110 $0.0088 $0.0095 696 604
2022-09-02 $0.0108 $0.0110 $0.0100 $0.0101 212 497
2022-09-01 $0.0112 $0.0112 $0.0101 $0.0111 174 887
2022-08-31 $0.0112 $0.0119 $0.0100 $0.0105 185 757
2022-08-30 $0.0110 $0.0112 $0.0100 $0.0100 124 026
2022-08-29 $0.0091 $0.0112 $0.0091 $0.0103 145 963
2022-08-26 $0.0098 $0.0119 $0.0090 $0.0109 274 794
2022-08-25 $0.0119 $0.0119 $0.0096 $0.0105 147 546
2022-08-24 $0.0108 $0.0108 $0.0096 $0.0108 175 606
2022-08-23 $0.0119 $0.0119 $0.0091 $0.0103 170 099
2022-08-22 $0.0120 $0.0120 $0.0102 $0.0105 111 668
2022-08-19 $0.0114 $0.0123 $0.0100 $0.0113 477 432
2022-08-18 $0.0129 $0.0129 $0.0114 $0.0120 79 834
2022-08-17 $0.0100 $0.0132 $0.0100 $0.0120 905 672
2022-08-16 $0.0111 $0.0111 $0.0100 $0.0101 391 611
2022-08-15 $0.0107 $0.0112 $0.0100 $0.0107 508 665
2022-08-12 $0.0100 $0.0112 $0.0100 $0.0110 371 616
2022-08-11 $0.0118 $0.0128 $0.0102 $0.0110 270 455
2022-08-10 $0.0108 $0.0118 $0.0102 $0.0118 286 769
2022-08-09 $0.0102 $0.0114 $0.0102 $0.0110 158 630
Click to get the best stock tips daily for free!

About Genocea Biosciences

Genocea Biosciences Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of so... GNCA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT